These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17617885)

  • 1. Healing of severe reflux esophagitis with PPI does not improve esophageal dysmotility.
    Xu JY; Xie XP; Song GQ; Hou XH
    Dis Esophagus; 2007; 20(4):346-52. PubMed ID: 17617885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep dysfunction in patients with GERD: erosive versus nonerosive reflux disease.
    Yi CH; Hu CT; Chen CL
    Am J Med Sci; 2007 Sep; 334(3):168-70. PubMed ID: 17873529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the severity of reflux esophagitis and the esophageal motility features on high resolution manometry].
    Hu ZW; Wang ZG; Wu JM; Tian SR; Zhang Y; Zhan XL; Du X; Wang F; Xin RH; Xu H
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(42):3306-3311. PubMed ID: 29141375
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there an association between hiatal hernia and ineffective esophageal motility in patients with gastroesophageal reflux disease?
    Conrado LM; Gurski RR; da Rosa AR; Simic AP; Callegari-Jacques SM
    J Gastrointest Surg; 2011 Oct; 15(10):1756-61. PubMed ID: 21830151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole.
    Peura DA; Pilmer B; Hunt B; Mody R; Perez MC
    Aliment Pharmacol Ther; 2013 Apr; 37(8):810-8. PubMed ID: 23451835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
    Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
    Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ineffective motility in lower third of esophagus. Length of involved esophagus and severity of gastroesophageal reflux disease].
    Icaza ME; Soto JC; Pedroza J; Valdovinos MA
    Rev Gastroenterol Mex; 2003; 68(1):34-40. PubMed ID: 12940097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexlansoprazole for the treatment of esophagitis and GERD.
    Davies SL
    Drugs Today (Barc); 2010 Feb; 46(2):75-80. PubMed ID: 20393635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity does not affect treatment outcomes with proton pump inhibitors.
    Sharma P; Vakil N; Monyak JT; Silberg DG
    J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of esophageal motility in gastroesophageal reflux disease with and without globus sensation.
    Tang Y; Huang J; Zhu Y; Qian A; Xu B; Yao W
    Rev Esp Enferm Dig; 2017 Dec; 109(12):850-855. PubMed ID: 29082739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
    Hong SJ; Ko BM; Jung IS; Ryu CB; Moon JH; Cho JY; Kim JO; Lee JS; Lee MS; Shim CS; Kim BS
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1662-5. PubMed ID: 17559356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between acid reflux and esophageal dysmotility in patients with gastroesophageal reflux disease].
    Yi ZH; Feng L; Wen MY; Liu JR; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):480-3. PubMed ID: 24941823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of gastroesophageal reflux disease: motility factors].
    Iwakiri K; Tanaka Y; Kawami N; Sano H; Kotoyori M; Sakamoto C
    Nihon Rinsho; 2007 May; 65(5):829-35. PubMed ID: 17511220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.
    Dunbar KB; Agoston AT; Odze RD; Huo X; Pham TH; Cipher DJ; Castell DO; Genta RM; Souza RF; Spechler SJ
    JAMA; 2016 May; 315(19):2104-12. PubMed ID: 27187303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.